MARKET

LLY

LLY

Lilly Eli & Co
NYSE
1,041.79
-12.50
-1.19%
After Hours: 1039.60 -2.19 -0.21% 19:35 12/17 EST
OPEN
1,064.30
PREV CLOSE
1,054.29
HIGH
1,064.30
LOW
1,036.41
VOLUME
3.73M
TURNOVER
--
52 WEEK HIGH
1,111.99
52 WEEK LOW
621.50
MARKET CAP
984.89B
P/E (TTM)
50.95
1D
5D
1M
3M
1Y
5Y
1D
Salesforce’s Agentforce Life Sciences Gains Traction with Another Healthcare Provider Onboard
TipRanks · 15h ago
Correction to Lilly Drug Trial Article on Dec. 11
Dow Jones · 15h ago
More pharmas expected to sign drug pricing deals with Trump on Friday - report
Seeking Alpha · 15h ago
3 Best ETFs to Invest In, According to AI Analyst, 12/17/2025
TipRanks · 16h ago
Eli Lilly’s Phase 2 Study on Imlunestrant: A Potential Game-Changer in Breast Cancer Treatment
TipRanks · 17h ago
Eli Lilly’s Pediatric COVID-19 Study on Baricitinib Terminated: Key Insights for Investors
TipRanks · 17h ago
WisdomTree U.S. Quality Growth Fund Experiences Big Outflow
NASDAQ · 17h ago
Pfizer Issues Soft 2026 View: What Does It Mean for the Stock's Future?
NASDAQ · 18h ago
More
About LLY
Eli Lilly and Company is a medicine company, which discovers, develops, manufactures, markets, and sells pharmaceutical products worldwide. Its cardiometabolic health products include Basaglar; Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, and others; Humulin, Humulin 70/30, and others; Jardiance; Mounjaro; Trulicity; Zepbound; VERVE-102; VERVE-201, and VERVE-301. Its oncology products include Cyramza, Erbitux, Tyvyt, and Verzenio. Its immunology products include Ebglyss, Olumiant, Omvoh, and Taltz. Its neuroscience products include Emgality and Kisunla. The Company is also engaged in radiopharmaceutical discovery, development, and manufacturing efforts, and clinical and pre-clinical radioligand therapies in development for the treatment of cancer. It is also developing an oral small molecule inhibitor of a4b7 integrin for inflammatory bowel disease (IBD). It is evaluating its novel gene therapy candidate, ixoberogene soroparvovec.

Webull offers Eli Lilly And Co stock information, including NYSE: LLY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LLY stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LLY stock methods without spending real money on the virtual paper trading platform.